Sunshine Biopharma, Inc.

US$2.71As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:SBFMHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (76.86%)
Div yield —
ROE (21.92%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 1.52
PE TTM —
TSR TTM (99.23%)
Mkt cap US$0.525M
ROIC (11.85%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$3.50
28.99%
(31.02%)
Hold 5|6|12|6|3
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.04
0.04
0.04
0.04
0.63%
(6.38%)
(4.16%)
(4.25%)
Revenue$M
0.050
0.050
0.049
0.049
(6.51%)
(3.81%)
(4.59%)
(2.30%)
Peers (US$0.525M)
Cap (US$)
PE
4.661M
—
0.527M
—
Capital
TTM
5Y
10Y
Leveragex
2.192
(0.054)
(0.049)
EBIT/Intx
1.600
0.502
0.530
Own earn%
54.61
(240.13)
(183.33)
Sh yield%
51.47
47.83
45.86
Owners
Insiders/Inst%
9.80
24.33
Short interest%
2.39
SBC / revenue%
5.02
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
19–29
$1 testx
0.0
Incr. ROIC%
3